Connection

John Colwell to Platelet Aggregation Inhibitors

This is a "connection" page, showing publications John Colwell has written about Platelet Aggregation Inhibitors.
Connection Strength

1.908
  1. Does aspirin use reduce cardiovascular risk in diabetes? Nat Rev Endocrinol. 2009 Apr; 5(4):188-90.
    View in: PubMed
    Score: 0.288
  2. An appraisal of aspirin therapy in diabetes. Curr Diab Rep. 2006 Dec; 6(6):409-10.
    View in: PubMed
    Score: 0.245
  3. Aspirin therapy in diabetes. Diabetes Care. 2004 Jan; 27 Suppl 1:S72-3.
    View in: PubMed
    Score: 0.200
  4. Antiplatelet agents for the prevention of cardiovascular disease in diabetes mellitus. Am J Cardiovasc Drugs. 2004; 4(2):87-106.
    View in: PubMed
    Score: 0.200
  5. Aspirin for primary prevention of cardiovascular events in diabetes. Diabetes Care. 2003 Dec; 26(12):3349-50.
    View in: PubMed
    Score: 0.199
  6. Aspirin and risk of hemorrhagic stroke. JAMA. 1999 Aug 25; 282(8):731-2; author reply 732-3.
    View in: PubMed
    Score: 0.148
  7. Aspirin therapy in diabetes mellitus. Diabetologia. 1997 Jul; 40(7):867.
    View in: PubMed
    Score: 0.127
  8. Antiplatelet drugs and prevention of macrovascular disease in diabetes mellitus. Metabolism. 1992 May; 41(5 Suppl 1):7-10.
    View in: PubMed
    Score: 0.089
  9. Clinical trials of antiplatelet agents in diabetes mellitus: rationale and results. Semin Thromb Hemost. 1991 Oct; 17(4):439-44.
    View in: PubMed
    Score: 0.085
  10. Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation. Diabetes Care. 2010 Jun; 33(6):1395-402.
    View in: PubMed
    Score: 0.078
  11. Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation. Circulation. 2010 Jun 22; 121(24):2694-701.
    View in: PubMed
    Score: 0.078
  12. Aspirin for the primary prevention of cardiovascular events. Drugs Today (Barc). 2006 Jul; 42(7):467-79.
    View in: PubMed
    Score: 0.059
  13. The platelet in diabetes: focus on prevention of ischemic events. Diabetes Care. 2003 Jul; 26(7):2181-8.
    View in: PubMed
    Score: 0.048
  14. Multifactorial aspects of the treatment of the type II diabetic patient. Metabolism. 1997 Dec; 46(12 Suppl 1):1-4.
    View in: PubMed
    Score: 0.033
  15. Aspirin for primary prevention of cardiovascular events in people with diabetes. J Am Coll Cardiol. 2010 Jun 22; 55(25):2878-86.
    View in: PubMed
    Score: 0.020
  16. Do platelets have anything to do with diabetic microvascular disease? Diabetes. 1983 May; 32 Suppl 2:14-9.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.